These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


79 related items for PubMed ID: 6608813

  • 1. Persistence and specificity of accessory cell impairment in M-MuLV neonatally injected mice.
    Biasi G, Saggin L, Dazzi F, Collavo D.
    Transplant Proc; 1983 Dec; 15(4):2125-7. PubMed ID: 6608813
    [No Abstract] [Full Text] [Related]

  • 2. Selective failure of accessory cell function in Moloney murine leukemia virus-tolerant mice.
    Biasi G, Collavo D, Chieco-Bianchi L.
    J Immunol; 1983 Jul; 131(1):16-8. PubMed ID: 6223070
    [Abstract] [Full Text] [Related]

  • 3. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [Abstract] [Full Text] [Related]

  • 4. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract] [Full Text] [Related]

  • 5. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).
    Zanovello P, Collavo D, Ronchese F, De Rossi A, Biasi G, Chieco-Bianchi L.
    Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521
    [Abstract] [Full Text] [Related]

  • 6. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice.
    Biasi G, Facchinetti A, Panozzo M, Zanovello P, Chieco-Bianchi L, Collavo D.
    J Immunol; 1991 Oct 01; 147(7):2284-9. PubMed ID: 1833453
    [Abstract] [Full Text] [Related]

  • 7. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
    Biasi G, Saggin L, Dazzi F, De Rossi A, Collavo D.
    J Immunol; 1983 Mar 01; 130(3):1447-50. PubMed ID: 6185589
    [Abstract] [Full Text] [Related]

  • 8. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P, Biasi G, Horvath C, Cerottini JC, MacDonald HR.
    J Immunol; 1998 Feb 15; 160(4):1659-65. PubMed ID: 9469422
    [Abstract] [Full Text] [Related]

  • 9. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G, Schurmans S, Berney M, Izui S, del Giudice G, Lambert PH.
    J Autoimmun; 1995 Apr 15; 8(2):177-92. PubMed ID: 7612147
    [Abstract] [Full Text] [Related]

  • 10. In vitro suppression of cytotoxic T cell generation by lymphocytes from mice rendered neonatally tolerant of class II MHC alloantigens.
    Powell TJ, Streilein JW.
    Transplantation; 1991 Aug 15; 52(2):383-6. PubMed ID: 1831305
    [No Abstract] [Full Text] [Related]

  • 11. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VIII. Characterization of suppressor cells.
    Deutsch O, Devens B, Naor D.
    Isr J Med Sci; 1980 Jul 15; 16(7):538-44. PubMed ID: 6447123
    [Abstract] [Full Text] [Related]

  • 12. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VII. Kinetic studies on various parameters of effects induced with suppressor cells.
    Deutsch O, Devens B, Naor D.
    Isr J Med Sci; 1980 Jul 15; 16(7):530-7. PubMed ID: 6447122
    [Abstract] [Full Text] [Related]

  • 13. Cell interactions in leukemia-associated immunosuppression: suppression of thymus-independent antibody responses by leukemia spleen cells (Moloney) in vitro is mediated by normal T cells.
    Caulfield MJ, Cerny J.
    J Immunol; 1980 Jan 15; 124(1):255-60. PubMed ID: 6965291
    [No Abstract] [Full Text] [Related]

  • 14. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that precursor cytotoxic T cells are present but silenced.
    Matriano JA, Socarras S, Streilein JW.
    J Immunol; 1994 Aug 15; 153(4):1515-26. PubMed ID: 8046230
    [Abstract] [Full Text] [Related]

  • 15. T cell recognition of Moloney sarcoma virus proteins during tumor regression. I. Lack of a requirement for macrophages and the role of blastogenic factors in T cell proliferation.
    Enjuanes L, Lee JC, Ihle JN.
    J Immunol; 1981 Apr 15; 126(4):1478-84. PubMed ID: 6970777
    [Abstract] [Full Text] [Related]

  • 16. The presence of Moloney virus induced antigen on antibody-producing cells.
    Celada F, Asjö B, Klein G.
    Clin Exp Immunol; 1970 Mar 15; 6(3):317-23. PubMed ID: 4909958
    [Abstract] [Full Text] [Related]

  • 17. T cell recognition of Moloney leukemia virus proteins. III. T cell proliferative responses against gp70 are associated with the production of a lymphokine inducing 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes.
    Ihle JN, Lee JC, Rebar L.
    J Immunol; 1981 Dec 15; 127(6):2565-70. PubMed ID: 6795277
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V, Hilbert D, Wolff L.
    Virology; 1994 Dec 15; 205(2):479-85. PubMed ID: 7975249
    [Abstract] [Full Text] [Related]

  • 19. [Resistance of AKR mice to the oncogenic action of Moloney murine sarcoma virus].
    Tsysina EN, Irlin IS.
    Biull Eksp Biol Med; 1971 Oct 15; 72(10):85-8. PubMed ID: 5126159
    [No Abstract] [Full Text] [Related]

  • 20. Clonal analysis of the T lymphocyte response to murine sarcoma virus-induced tumors.
    Brunner KT, Weiss A, Cerottini JC, MacDonald HR.
    Transplant Proc; 1982 Sep 15; 14(3):556-8. PubMed ID: 6217605
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.